Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.
Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.
DOCUSIGN director Peter Solvik reported equity compensation and a routine option-style exercise. On June 1, 2026, he received a grant of 4,384 Restricted Stock Units, each representing one share of common stock, vesting quarterly over one year starting on that date, subject to continued service.
On May 29, 2026, Solvik exercised 729 RSUs for 729 shares of common stock at an exercise price of $0.00, bringing his directly held common stock to 8,970 shares. The filing also lists indirect holdings, including 6,458 shares held by his spouse, 65,558 shares held by children’s trusts, 120,253 shares held by a trust, and 3 shares held by a family partnership. No open-market purchases or sales were reported.
DOCUSIGN director Peter Solvik reported equity compensation and a routine option-style exercise. On June 1, 2026, he received a grant of 4,384 Restricted Stock Units, each representing one share of common stock, vesting quarterly over one year starting on that date, subject to continued service.
On May 29, 2026, Solvik exercised 729 RSUs for 729 shares of common stock at an exercise price of $0.00, bringing his directly held common stock to 8,970 shares. The filing also lists indirect holdings, including 6,458 shares held by his spouse, 65,558 shares held by children’s trusts, 120,253 shares held by a trust, and 3 shares held by a family partnership. No open-market purchases or sales were reported.
DOCUSIGN, INC. director Cain A. Hayes reported routine equity compensation activity. On June 1, 2026, Hayes received a grant of 4,384 Restricted Stock Units (RSUs), each representing a right to one share of common stock, vesting quarterly over one year subject to continued service.
On May 29, 2026, Hayes exercised a prior RSU award, converting 729 RSUs into an equal number of common shares. Following these transactions, Hayes directly holds 15,717 shares of common stock and 4,384 RSUs, with no reported stock sales in this filing.
DOCUSIGN, INC. director Cain A. Hayes reported routine equity compensation activity. On June 1, 2026, Hayes received a grant of 4,384 Restricted Stock Units (RSUs), each representing a right to one share of common stock, vesting quarterly over one year subject to continued service.
On May 29, 2026, Hayes exercised a prior RSU award, converting 729 RSUs into an equal number of common shares. Following these transactions, Hayes directly holds 15,717 shares of common stock and 4,384 RSUs, with no reported stock sales in this filing.
DocuSign director Irving Blake reported equity compensation activity. Blake received a grant of 4,384 restricted stock units (RSUs), each representing a contingent right to one share of DocuSign common stock. These RSUs have a vest commencement date of June 1, 2026 and will vest in equal quarterly installments over one year, with the final tranche vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service.
On May 29, 2026, 729 RSUs were exercised and converted into 729 shares of common stock, reflecting a derivative exercise rather than an open-market purchase. Following this transaction, Blake directly held 26,093 shares of DocuSign common stock. The RSUs do not expire; they either vest or are canceled before vesting, so these transactions primarily reflect routine director compensation and vesting mechanics.
DocuSign director Irving Blake reported equity compensation activity. Blake received a grant of 4,384 restricted stock units (RSUs), each representing a contingent right to one share of DocuSign common stock. These RSUs have a vest commencement date of June 1, 2026 and will vest in equal quarterly installments over one year, with the final tranche vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service.
On May 29, 2026, 729 RSUs were exercised and converted into 729 shares of common stock, reflecting a derivative exercise rather than an open-market purchase. Following this transaction, Blake directly held 26,093 shares of DocuSign common stock. The RSUs do not expire; they either vest or are canceled before vesting, so these transactions primarily reflect routine director compensation and vesting mechanics.
DocuSign director James A. Beer reported mixed equity activity, including a small open-market sale and routine equity awards. He sold 450 shares of common stock on June 2, 2026 at $55.04 per share in an open-market transaction under a pre-arranged Rule 10b5-1 plan, leaving him with 15,036 directly held shares. On May 29, 2026, 729 Restricted Stock Units (RSUs) converted into 729 shares of common stock as they vested. He also holds 5,543 shares indirectly through a trust. On June 1, 2026, he received a grant of 4,384 RSUs, each representing a right to one share of common stock, scheduled to vest in equal quarterly installments over one year, subject to continued service and the timing of the company’s next annual stockholder meeting.
DocuSign director James A. Beer reported mixed equity activity, including a small open-market sale and routine equity awards. He sold 450 shares of common stock on June 2, 2026 at $55.04 per share in an open-market transaction under a pre-arranged Rule 10b5-1 plan, leaving him with 15,036 directly held shares. On May 29, 2026, 729 Restricted Stock Units (RSUs) converted into 729 shares of common stock as they vested. He also holds 5,543 shares indirectly through a trust. On June 1, 2026, he received a grant of 4,384 RSUs, each representing a right to one share of common stock, scheduled to vest in equal quarterly installments over one year, subject to continued service and the timing of the company’s next annual stockholder meeting.
DOCUSIGN, INC. director Anna Marrs reported a mix of equity compensation and routine trading activity. She sold 365 shares of common stock on June 2, 2026 at $55.04 per share under a pre-arranged Rule 10b5-1 trading plan, and held 12,615 common shares afterward.
On May 29, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 common shares, fully settling that RSU lot. On June 1, 2026, she received a grant of 4,384 RSUs, each representing one future share of common stock, vesting quarterly over one year based on continued service.
DOCUSIGN, INC. director Anna Marrs reported a mix of equity compensation and routine trading activity. She sold 365 shares of common stock on June 2, 2026 at $55.04 per share under a pre-arranged Rule 10b5-1 trading plan, and held 12,615 common shares afterward.
On May 29, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 common shares, fully settling that RSU lot. On June 1, 2026, she received a grant of 4,384 RSUs, each representing one future share of common stock, vesting quarterly over one year based on continued service.
DOCU-related Form 144 notice lists a proposed sale of 365 shares of Common stock associated with Morgan Stanley Smith Barney LLC, with a filing date of 06/02/2026 and a reported trade date of 05/29/2026. The filing also lists two prior dispositions in March 2026 of 363 and 365 shares, with reported amounts 16817.79 and 16432.30.
DOCU-related Form 144 notice lists a proposed sale of 365 shares of Common stock associated with Morgan Stanley Smith Barney LLC, with a filing date of 06/02/2026 and a reported trade date of 05/29/2026. The filing also lists two prior dispositions in March 2026 of 363 and 365 shares, with reported amounts 16817.79 and 16432.30.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting a proposed sale of 450 shares of restricted common stock associated with James A. Beer. The restricted shares are dated 05/29/2026, and a prior sale of 450 shares is listed on 03/03/2026.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting a proposed sale of 450 shares of restricted common stock associated with James A. Beer. The restricted shares are dated 05/29/2026, and a prior sale of 450 shares is listed on 03/03/2026.
Trollope Rowan M reported acquisition or exercise transactions in this Form 4 filing.
DOCUSIGN, INC. director Rowan M. Trollope received a grant of 10,438 restricted stock units on May 8, 2026. Each RSU represents a contingent right to receive one share of DocuSign common stock.
The 10,438 RSUs will vest in twelve equal quarterly installments over three years, starting on May 2, 2026, as long as Trollope remains a service provider through each vesting date. The RSUs do not expire; they either vest into common shares or are canceled before vesting.
DOCUSIGN, INC. director Rowan M. Trollope has filed an initial Form 3, which is a required statement of beneficial ownership for insiders. This filing lists him as a director but does not report any stock transactions or derivative holdings in the provided data.